Erica Petrlik
Bristol-Myers Squibb (United States)(US)Bristol-Myers Squibb (Sweden)(SE)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Multiple Myeloma Research and Treatments, Chronic Myeloid Leukemia Treatments, Parathyroid Disorders and Treatments
Most-Cited Works
- → Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis(2022)77 cited
- → Effect of Education on Blood Pressure Control in Elderly PersonsA Randomized Controlled Trial(2006)45 cited
- → Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma(2021)39 cited
- → Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis(2024)22 cited
- → Retrospective Outcome Data for Hematopoietic Stem Cell Transplantation in Patients with Concurrent Coronary Artery Disease(2010)14 cited
- → T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies(2017)13 cited
- → Graded Renal Response Criteria for Light Chain (AL) Amyloidosis(2021)10 cited
- → Graded Cardiac Response Criteria for AL Amyloidosis: The Impact of Depth of Cardiac Response on Survival(2021)8 cited
- → Phase 1b OMNIVERSE trial: Safety and tolerability of oral azacitidine (Oral-AZA) in combination with venetoclax (VEN) for treatment of acute myeloid leukemia.(2023)2 cited
- → Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML‐001(2023)2 cited